Navigation Links
Flame retardant ban reduces exposures in pregnant women

Phasing out the use of potentially harmful flame retardants in furniture foam, electronics and plastics has lowered pregnant women's exposure to the substances, which are associated with health problems in both pregnant women and their newborns. The new study, which was published in the ACS journal Environmental Science & Technology, was the first to examine the phase-out's effectiveness.

Ami Zota, an assistant professor at George Washington University, and colleagues explain that furniture, electronics and plastics manufacturers commonly used flame retardants called polybrominated diphenyl ethers (PBDEs) in their products starting in the 1970s. In 2003-2004, California banned the manufacture and import of certain PBDEs, and the U.S. phased out their production. However, human exposure continues from house dust, food and use of older products containing the flame retardants. PBDEs are associated with thyroid hormone problems in pregnant women and their children. These children also are at greater risk for having poor attention spans and reduced IQs. No one knew whether the ban actually reduced human exposures, so Zota's team investigated the issue.

They found a 65 percent drop over three years (2008-2011) in the levels of PBDEs in blood samples from pregnant women who visited San Francisco General Hospital, suggesting that the ban had a positive impact. However, the authors caution that because the substances remain in the environment for a long time, exposure will likely continue. The researchers say this study shows the importance of biomonitoring (measuring the presence of substances in the human body) to track changes in levels in the human population, and the value of that information in shaping public health policy.


Contact: Michael Bernstein
American Chemical Society

Page: 1

Related biology news :

1. Social stress and the inflamed brain
2. Potentially toxic flame retardants found in many US couches
3. New study: Many flame retardants in house dust -- unsafe levels
4. Socioeconomics may affect toddlers exposure to flame retardants
5. Subdiaphragmatic vagotomy reduces intake of sweet-tasting solutions in rats
6. Type 2 diabetes patients transplanted with own bone marrow stem cells reduces insulin use
7. HIV prevention among female sex workers in India reduces HIV and syphilis
8. Gym class reduces probability of obesity, study finds for first time
9. Drug reduces fat by blocking blood vessels
10. Early antiretroviral treatment reduces viral reservoirs in HIV-infected teens
11. Prenatal DHA reduces early preterm birth, low birth weight
Post Your Comments:
(Date:10/7/2015)... -- --> --> According ... third quarter 2015 amounted to around 960 MSEK. This exceeds ... was communicated 20 August 2015. --> ... a continued growing demand for the company,s products, the revenues ... than during the third quarter. The revenue guidance for 2015 ...
(Date:10/6/2015)... 2015  Maverix Biomics, Inc., a leading genomic ... software portfolio with the debut of its RNA-Seq ... in eukaryotes. The software is integrated into the ... analysis solution that leverages proven open-source algorithms and ... efforts. Garry Nolan,s laboratory at ...
(Date:10/1/2015)... , Oct. 1, 2015  Biometrics includes diverse ... human body characteristics, such as fingerprints, eye retinas, ... Adoption of biometrics technology has been constantly increasing ... last five years. In addition to the most ... fingerprint recognition, other means of biometric authentication are ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... October 13, 2015 ARRY ), ... (NASDAQ: JUNO ), and Progenix Pharmaceuticals, Inc. (NASDAQ: ... Life Sciences Corp. (OTCQX: AVXLD), Juno Therapeutics, Inc. (NASDAQ: ... PGNX ) --> Cooperative research and development ... can potentially lead to advancements in the treatment of ...
(Date:10/13/2015)... JACKSONVILLE, Florida , October 13, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, will be a featured presenting company ... at the Wyndham Grand Hotel in ... --> TapImmune, Inc. (TPIV), a clinical-stage immunotherapy ...
(Date:10/13/2015)... ... October 13, 2015 , ... Clinovo recently appointed Jeff Parr and Ed Donaldson ... clinical data solutions business. , Jeff Parr has spent the past decade providing quality ... Dennison, Thermo Fisher, and Ab Sciex to name a few. He is based ...
(Date:10/13/2015)... the United States , Canada ... 14% of all new cases of kidney cancer.   --> ... and Europe .  PRCC represents about 14% ... Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) today announces that Hutchison ... ("AstraZeneca") have completed enrolment in a global Phase II study of ...
Breaking Biology Technology: